Regenerative Medicine by Amniotic Membrane to Offer Treatment for Several Diseases

2 April 2020: The amniotic membrane market is likely to witness growth due to demand for its applications in surgical graft, management of wounds, and biological bandage for the treatment. It is the innermost layer of placenta and is used for wound healing and contains bacteriostatic and pain reduction properties. Amniotic membranes are used for reconstruction of the conjunctiva surface, surgical wounds, excisions, venous and pressure leg ulcers, and regenerative medicine. Factors fueling the growth of the market are rise in the number of surgeries being performed and R&D investments in the field of stem cell and regenerative medicine.

Ambulatory Surgical Centers (ASCs) Promote Quick Patient Recovery 

On the basis of end use, the market is segmented into Ambulatory Surgical Centers (ASCs), hospitals, research, specialty clinics, and academic institutes. Hospitals offer treatment for a wide range of diseases and accounts for the largest market share. Frequent visits by patients and facilities of surgical interventions are the factors responsible for the growth of this segment.

Increasing usage of amniotic membranes in ASCs is due to its effective wound recovery properties and reduced visits to hospitals. Hence, ASC segment is anticipated to achieve a rapid growth over the next few years. Amniotic membrane is used in specialty clinics such as plastic surgery clinics, burn centers, dermatology clinics, and others require methods to prevent infections and promote effective wound healing thus facilitating market growth. Amniotic membrane also promotes stem cells and regenerative medicine propelling growth of the market.

Market Insights

High demand for the product due to its applications in cosmetic surgeries is boosting the market growth. It is used in reconstructive procedures, which is another reason for its high demand. It has other benefits such as reduced fibrosis and anti-inflammatory properties that have advantages in medical treatments thus fueling the demand. Research and academic institutes are also witnessing growth due to high R&D investments by leading companies and hospitals. 

Some of the major companies of the amniotic membrane market are Amnio Technology, LLC; Alliqua BioMedical, Inc.; Human Regenerative Technologies, LLC; Applied Biologics LLC; MiMedx Group, Inc.; DermaSciences; Katena Products, Inc.; Amniox Medical, Inc.; Skye Biologics, Inc.; and Organogensis, Inc.